– Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company specializing in the development of treatments that aim to slow the degenerative processes associated with aging and to improve functional outcomes for patients with age-related diseases, including respiratory failure in patients with COVID-19, announces that its CEO, Stanislas Veillet, will attend and present at the “HC Wainwright 25th Annual Global Investment Conference”, which takes place from September 11 to 13, 2023 in New York.
2023-09-04 21:00:00
#Biophytis #participate #25th #Global #Investment #Conference #Wainwright #York